The new medical terminology used in Ireland could be the result of a collaboration between two major players in the medical field.

The medical device market in Ireland is worth €3.5 billion ($4.6 billion) according to the Irish Medicines and Healthcare Products Regulatory Agency (IMPRASA).

It has been estimated that this number is on track to grow by over 100% by 2021.

However, the medical device industry is struggling to find its footing, as the Irish medical profession is suffering from an influx of inexperienced and under-qualified doctors, nurses and midwives.

In a bid to attract more experienced doctors, IMPRASAs chief executive Dr Michael McGrath said the introduction of the medical instrument terminology could be a game changer for the medical profession.

“The medical term in Ireland has not been well defined by the Irish Medical Board (IMB) in recent years.

However, this will hopefully change in the coming years,” Dr McGrath told RTE Radio One.

Dr McGrath has previously described the Irish healthcare industry as a “toxic, polluted mess” and said the medical term would allow medical professionals to work together more effectively.

He said the proposed medical term could provide a new opportunity for medical professionals in the field to learn together.

Dr Michael McGrathan says the medical system needs to be able to deal with more patients with the same level of care, which means more time for the health system to allocate resources and invest in the healthcare of the people.

He explained that a term such as ‘surgical instruments’ could bring in more doctors and nurses.

“In this particular area, we are actually having to get the whole system to be more efficient, to be quicker to respond, to get to know patients and then to give them the best care.

I think that will help to bring in some of the experienced people in the industry to join us in the future,” he said.

Dr David Molloy from the Department of Medical Technology and Innovation (DMITI) agreed that the medical terminology could benefit the medical industry.

“One of the great benefits of medical devices in Ireland for the Irish population is that they are not necessarily available to everyone, but to some it is the best option,” he told Rte Radio One, adding that this has helped the health sector to diversify its business models.

Dr Mollay said that medical technology could be used for many different purposes, such as diagnostics and treatment.

“This can be used in many different ways, as we are seeing in the case of diabetes and the management of cancer, so this could be in use in a lot of different ways,” he explained.

Dr John O’Sullivan, Director of DMITI, agreed, saying that medical terminology is a vital part of modern healthcare.

“We have a need to be aware of the issues of people living with chronic conditions, which is an issue that is not being addressed, so medical terminology has an impact on that and we need to take that into account,” he added.

However Dr McGrathan said that the introduction in the Medical Instrument Terms of Reference is not a silver bullet.

“There are no guarantees in terms of it being used by every single patient.

I am sure there will be people who will take this as an opportunity to improve their care, but I am not sure that it will be a silver-bullet solution to everything,” he acknowledged.

Dr O’Neill also agreed that some people might be disappointed by the introduction.

“It may be that people will be sceptical of this and maybe not be keen on it.

That is certainly a possibility.

It may be a few people who may be concerned,” he stated.